New Vitamin D Analogs
- 1 May 2001
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 14 (3) , 229-230
- https://doi.org/10.1046/j.1525-139x.2001.00057-3.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Differential Effects of 1,25-Dihydroxy-Vitamin D3 and 19-Nor-1,25-Dihydroxy-Vitamin D2 on Calcium and Phosphorus Resorption in BoneJournal of the American Society of Nephrology, 1999
- 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.Journal of the American Society of Nephrology, 1998
- Intermittent oral 1&agr;-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patientsNephrology Dialysis Transplantation, 1998
- Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismKidney International, 1997
- 1 -Hydroxy-vitamin D2: a new look at an 'old' compoundNephrology Dialysis Transplantation, 1996
- A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemiaAmerican Journal of Kidney Diseases, 1995
- Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRDKidney International, 1994